common.study.topics.clinical

Xanthohumol Metabolism and Signature

common.study.values.description

Xanthohumol Metabolism and Signature

A pilot study to assess the safety and tolerability of oral xanthohumol in humans, to identify a biological signature of xanthohumol exposure, and to characterize the role of xanthohumol metabolism by intestinal microorganisms in that signature.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Xanthohumol

The xanthohumol supplement will be administered in a capsule. Participants in the experimental arm will consume the capsule once per day, with the first meal. The intervention will extend for 8 weeks.

Drug - Placebo oral capsule

The placebo (vehicle) will be administered in a capsule. Participants in the placebo arm will consume the capsule once per day, with the first meal.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Xanthohumol Metabolism and Signature (XMaS) in Healthy Adults

common.study.values.clinical-trial-id

NCT03735420

participant.views.study.view.id

av2Yra